CD4 and myocarditis: Indeed, application of CAPs in CVB3-infected mice reduced cardiac MNC activation, increased CD4+ and CD8+ T cell apoptosis in the spleen, and raised the % of T regulatory cells, which recently have been shown to protect against CVB3-induced myocarditis [35].